Form 4 for DGX Quest Diagnostics
Accepted 2022-10-27 00:00:00 ET · period of report 2022-10-26 · accession 0001022079-22-000143 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-10-27 | 2022-10-26 | DGX | DEPPE MICHAEL J | VP, CAO, Corp. Ctrl | M - OptEx | $53.79 | +15.5K | 41.1K | +60% | +$833.6K |
| D | 2022-10-27 | 2022-10-26 | DGX | DEPPE MICHAEL J | VP, CAO, Corp. Ctrl | S - Sale+OE | $145.00 | -15.5K | 32.0K | -33% | -$2.25M |
| DM | 2022-10-27 | 2022-10-26 | DGX | DEPPE MICHAEL J | VP, CAO, Corp. Ctrl | M - OptEx | $53.79 | -15.5K | 0 | -100% | -$833.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-26 | M | A | 6,371 | $56.12 | 47,503 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-26 | S | D | 15,497 | $145.00 | 32,013 | D | — | — | (F2) The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. |
| 3 | Common | Common Stock | 2022-10-26 | M | A | 9,126 | $52.17 | 41,132 | D | — | — | |
| 4 | Derivative | Non-Qualifed Stock Option (right to buy) | 2022-10-26 | M | D | 9,126 | $52.17 | 0 | D | $52.17 · — to 2024-02-13 | 9,126 Common Stock | (F4) The options vested in three annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017. |
| 5 | Derivative | Non-Qualifed Stock Option (right to buy) | 2022-10-26 | M | D | 6,371 | $56.12 | 0 | D | $56.12 · — to 2023-02-25 | 6,371 Common Stock | (F5) The options vested in three annual installments beginning with the first on February 25, 2014, the second on February 25, 2015 and the final on February 25, 2016. |